LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo.
López FJ, Ardecky RJ, Bebo B, Benbatoul K, De Grandpre L, Liu S, Leibowitz MD, Marschke K, Rosen J, Rungta D, Viveros HO, Yen WC, Zhi L, Negro-Vilar A, Miner JN.
López FJ, et al.
Endocrinology. 2008 May;149(5):2080-9. doi: 10.1210/en.2007-1353. Epub 2008 Jan 24.
Endocrinology. 2008.
PMID: 18218700